11 articles for thisTarget
              
              The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors.

University of Texas Medical Branch
 
Structure-Activity Relationship Studies of Substituted 2-(Isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl Cyanide Analogues: Identification of Potent Exchange Proteins Directly Activated by cAMP (EPAC) Antagonists.

University of Texas Medical Branch
 
Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC).

University of Texas Medical Branch
 
Identification and characterization of small molecules as potent and specific EPAC2 antagonists.

University of Texas Medical Branch
 
5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP.

University of Texas Medical Branch
 
Chemical synthesis and biological activity of novel brominated 7-deazaadenosine-3',5'-cyclic monophosphate derivatives.

University Hospital Jena
 
Structure-activity relationships of 2-substituted phenyl-N-phenyl-2-oxoacetohydrazonoyl cyanides as novel antagonists of exchange proteins directly activated by cAMP (EPACs).

University of Texas Medical Branch
 
Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets.

University of Texas Medical Branch
 
Structure-Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors.

Institute For Research In Cancer and Allied Diseases
 
Identification of novel 2-(benzo[d]isoxazol-3-yl)-2-oxo-N-phenylacetohydrazonoyl cyanide analoguesas potent EPAC antagonists.

University of Texas Medical Branch
 
Inhibitors of hepatitis C virus replication

Merck Sharp & Dohme